Clinical Research Directory
Browse clinical research sites, groups, and studies.
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Sponsor: University of Florence
Summary
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Official title: RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-03-26
Completion Date
2027-09
Last Updated
2026-01-21
Healthy Volunteers
No
Interventions
Rimegepant 75 mg
Patients using Rimegepant 75 mg orally disintegrating tablet every other day as migraine prevention
Locations (2)
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, Italy
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, Italy